managingmyeloma.com Traffic Analytics & Website Stats

Managing Myeloma is an educational initiative dedicated to developing tools, information, and resources that support improved therapeutic outcomes for patients diagnosed with multiple myeloma.
3.00

managingmyeloma.com is a domain having .com extension. managingmyeloma.com is a health/health conditions and concerns website. managingmyeloma.com gets 11,607 traffic per month, the site is estimated to be worth $1,658.00. Over the last three months, managingmyeloma.com's global ranking has increased from 8,018,512 to 1,991,926. managingmyeloma.com's traffic has decreased by 18.19% compared to last month, which is already a sign. Which countries sent the most traffic to managingmyeloma.com lately? Last month USA was the top country sending traffic to managingmyeloma.com. managingmyeloma.com's audience is 58.06% male and 41.94% female. The largest age group of visitors are 25 - 34 year olds.

Updated 8 months ago
Web Analysis
Traffic Report
Monthly Unique Visitors:

2,303

Monthly Pageviews:

11,607

Estimated Valuation
Income Per Day:

$ 3

Estimated Worth:

$ 1,658

Geography & Country Targeting
Countries Total Count:

2

Hot Country & Region:

USA

Search keywords & Backlinks
Keywords Total Count:

0

Backlinks Sites:

1

Global Ranks
Global Rank:

1,991,926

Country Rank:

2,218

Global Rank Change
Global Rank Change:

-213,530

Country Rank Change:

+1,761,338

  • Web Information
  • HTTP Information
  • Whois Information

Web Server Information

  • Hosted IP Address:

    0.0.0.0

  • Hosted Country:

    unknow

  • Location Latitude:

    0

  • Location Longitude:

    0

Page Title of managingmyeloma.com

Home

Meta Description of managingmyeloma.com

Managing Myeloma is an educational initiative dedicated to developing tools, information, and resources that support improved therapeutic outcomes for patients diagnosed with multiple myeloma.

Meta Tags of managingmyeloma.com

abnormal acute renal failure adverse effects adverse events agent Alkeran allogeneic American Society for Blood and Marrow Transplantation American Society of Clinical Oncology American Society of Hematology amyloidosis anticoagulant Antonio Palumbo Aredia ASCO ASH aspirin asymptomatic autologous stem cell transplant Bence-Jones best practice beta 2 microglobulin biopsy bisphosphonate Blade response criteria blood bone bone density bone disease bone marrow bone pain bone survey bortezomib bortezomib resistance calcium cancer carfilzomib Center for Disease Control chemotherapy chromosome clinical practice clinical study clinical trial complete remission complete response compression fracture conditioning regimen consolidation control creatinine creatinine clearance cyclophosphamide cytogenetics cytotoxic Decadron deep vein thrombosis deletion denosumab dexamethasone diagnosis disease dose dose modification dose reduction dose-limiting Doxil doxorubicin drug drug resistance drugs duration of response Durie Salmon Eastern Cooperative Oncology Group education elderly eligible enoxaparin European Group for Blood and Marrow Transplantation evidence extramedullary failure first line fluorescence in situ hybridization fractures free light chain genetics guidelines hematologist hematology heparin herbal high risk history hypercalcemia IFM imaging IMF IMiDs immunofixation immunoglobulins immunohistochemistry immunomodulatory drugs IMWG IMWG criteria incidence induction International Bone Marrow Transplant Registry International Myeloma Foundation International Myeloma Working Group International Staging System ISS Staging System Journal of Clinical Oncology kidney disease kidney failure kyphoplasty lenalidomide lytic lesions M component m protein M spike maintenance therapy management Mayo Clinic melphalan MGUS microglobulin MMRC MMRF mobilization monoclonal gammopathy Mozobil multiple myeloma Multiple Myeloma Research Foundation myeloma myeloma treatment resources National Comprehensive Cancer Network NCCN neuropathic neuropathy neutropenia neutropenic new nonsecretory myeloma novel nurse nursing oncology oncologist oncology nurse society osteolytic osteonecrosis osteonecrosis of the jaw overall response rate overall survival pain pamidronate paraprotein partial response pegylated doxorubicin perifosine peripheral neuropathy pharmacy pharmacist physician plasma cell plasma cell disorder plasmacytomas plasmacytosis Plerixafor pomalidomide prednisone prevention prognosis prognostic factors progression progression free survival progressive proteasome inhibitor proteinuria pulmonary embolism QoL rate reduced intensity referral refractory relapsed remission renal residual disease response response criteria reversal Revlimid risk risk factors risk stratification safety serum albumin serum creatinine serum free light chains serum monoclonal M protein serum monoclonal protein side effects skeletal related events smoldering myeloma Southwest Oncology Group staging stem cell collection stem cell mobilization stem cell transplant survival rate study symptomatic thalidomide Thalomid therapeutic thrombocytopenia thromboembolism time to progression time to response toxicity translocation transplantation treatment treatment goals treatments urine protein electrophoresis Velcade venous thromboembolism very good partial response VTE zoledronic acid zoledronate Zometa Kenneth Anderson Paul Richardson Ann Mohrbacher Sagar Lonial Sergio Giralt Rafael Fonseca Carol Viele Kena Miller Beth Faiman Sundar Jagannath William Bensinger Robert Orlowski Rubern Nievisky Shaji K. Kumar Jean-Luc Harousseau How to treat multiple myeloma How to treat myeloma How to stage multiple myeloma How do I stage multiple myeloma? How do I stage myeloma? side effects of multiple myeloma treatments myeloma cardiac issues relapsed myeloma multiple myeloma treatment multiple myeloma staging multiple myeloma ISS Staging creatinine clearance and dose adjustment multiple myeloma drugs multiple myeloma risk stratification multiple myeloma response assessment Multiple Myeloma Differential Diagnosis Multiple Myeloma Differential Diagnoses

Website Inpage Analysis

  • H1 Headings:

    0

  • H2 Headings:

    0

  • H3 Headings:

    2

  • H4 Headings:

    0

  • H5 Headings:

    0

  • H6 Headings:

    0

  • Total IFRAMEs:

    0

  • Total Images:

    24

  • Total Forms:

    3

  • Total Scripts:

    19

  • Google Adsense:

    No Data

  • Google Analytics:

    UA-1580145

HTTP Header Analysis

HTTP/1.1 200 OK
Date: Tue, 12 Sep 2023 00:33:38 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
P3P: CP="NOI ADM DEV PSAi COM NAV OUR OTRo STP IND DEM"
Expires: Wed, 17 Aug 2005 00:00:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Last-Modified: Tue, 12 Sep 2023 00:33:38 GMT
Vary: Accept-Encoding,User-Agent
CF-Cache-Status: DYNAMIC
Server: cloudflare
CF-RAY: 80540f653e7797ed-SJC
Content-Encoding: gzip
alt-svc: h3=":443"; ma=86400

Full WHOIS Lookup

Domain Name: MANAGINGMYELOMA.COM
Registry Domain ID: 1510088018_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2023-07-25T11:03:50Z
Creation Date: 2008-07-24T15:52:16Z
Registry Expiry Date: 2024-07-24T15:52:16Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: DEAN.NS.CLOUDFLARE.COM
Name Server: JESSICA.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2023-09-17T04:14:43Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
managingmyeloma.com

Similarly Ranked Websites